血糖値モニタリング装置のアジア市場予測2018-2026

◆英語タイトル:ASIA PACIFIC GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026
◆商品コード:INKW803057
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2108年2月19日
◆ページ数:120
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アジア
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥140,000見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥168,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD2,000 ⇒換算¥224,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

KEY FINDINGSThe Asia-Pacific Continuous Glucose Monitoring System (CGMS) market is predicted to evolve at 36.69% CAGR over the forecast period of 2018-2026, collecting a total of $3500.6 million.
While the Asia-Pacific Self-Monitoring of Blood Glucose (SMBG) market is predicted to evolve at 10.60% CAGR over the forecasted period, collecting a total of $6026.4 million by the end of 2026.
MARKET INSIGHTS
Over the last three decades, there has been an exponential increase in the number of diabetic patients, particularly in developing economies where more than 80% of the people are living with diabetes. The prevalence rate of diabetes is said to be increasing in developing countries owing to rapid and ongoing socioeconomic transition, and as a result, the healthcare expenditure had risen. This increase in expenditure is anticipated to create opportunities for the CGMS market in the upcoming years. China’s glucose monitoring system market accounted for the highest revenue share in 2017, and the country currently has the highest diabetes prevalence rate because of the growing population.
COMPETITIVE INSIGHTS
Asia-Pacific region enjoys a presence of eminent market players like Terumo, Wockhardt, I-SENS Inc., Morpen Laboratories, Apex Biotechnology Corp., Arkray Inc., Shanghai Pharma, Carewell Biotech Pvt. Ltd., Pharmaco, and others.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE STUDY MARKET
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.2. BOTTOM-UP APPROACH
2.3. TOP DOWN APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. CGMS MARKET IS ANTICIPATED TO BE A DEVELOPED MARKET
3.2.2. SELF-MONITORING OF BLOOD GLUCOSE HAS HUGE MARKET OPPORTUNITY
3.2.3. COLLABORATION OF SIGNIFICANT COMPANIES TO DEVELOP INTEGRATED CGMS-ENABLED INSULIN PUMPS
4. MARKET OVERVIEW
4.1. DRIVERS AND IMPACT
4.1.1. RISE IN THE INCIDENCE OF DIABETES
4.1.2. INCREASE IN HEALTHCARE EXPENDITURE
4.1.3. INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
4.1.4. TECHNOLOGY INTEGRATION
4.1.5. INCREASING CGMS AND SMBG AFFORDABILITY
4.1.6. TECHNOLOGICAL ADVANCES IN GMS DEVICES
4.1.7. AWARENESS AMONG THE GENERAL POPULATION
4.2. RESTRAIN AND IMPACT
4.2.1. HINDERANCE FROM GOVERNMENT REGULATIONS
4.2.2 INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
4.2.3. LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
4.3. CHALLENGES
4.3.1. INTENSE COMPETITION AMONG VENDORS
4.3.2. INACCURACY IN READING OF GMS DEVICES
4.3.3. INCREASINGLY STRINGENT GOVERNMENT REGULATIONS
5. CGMS MARKET SEGMENTATION
5.1. MARKET BY COMPONENT TYPE 2018-2026
5.1.1. SENSORS
5.1.2. TRANSMITTERS AND RECEIVERS
5.1.3. INSULIN PUMP
5.2. MARKET BY END USERS 2018-2026
5.2.1. HOME SETTINGS
5.2.2. DIAGNOSTICS AND CLINICS
5.2.3. HOSPITALS
6. SMBG MARKET
7. SMBG MARKET SEGMENTATION
7.1. MARKET BY COMPONENT TYPE 2018-2026
7.1.1. TEST STRIPS
7.1.2. GLUCOSE METER
7.1.3. LANCETS
7.2. MARKET BY END USERS 2018-2026
7.2.1. HOME SETTINGS
7.2.2. CLINICS
7.2.3. HOSPITALS
8. KEY ANALYTICAL
8.1. 5 FORCES ANALYSIS
8.1.1. THREAT OF NEW ENTRANT
8.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIER
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. MERGER AND ACQUISITIONS
8.3. KEY BUYING CRITERIA
8.4. KEY TRENDS
8.4.1. DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
8.4.2. MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
8.4.3. INCREASING EFFORTS TOWARDS SPREAD OF AWARENESS
8.4.4. INCREASE IN NON-INVASIVE DEVICES
8.4.5. ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE
8.5. REGULATION OF BLOOD SUGAR
8.6. INCIDENCE AND PREVALENCE OF DIABETES FOR VARIOUS COUNTRIES
9. REGIONAL ANALYSIS
9.1. ASIA-PACIFIC (APAC)
9.1.1. CHINA
9.1.1.1. CHINA HEALTH AND HEALTHCARE
9.1.1.2. CHINA PHARMACEUTICAL MARKET
9.1.1.3. CHINA DIABETES MARKET
9.1.1.4. MARKET TRENDS
9.1.2. INDIA
9.1.2.1. INDIA HEALTH AND HEALTHCARE
9.1.2.2. INDIA REGULATORY CHANGES
9.1.2.3. INDIA PHARMACEUTICAL MARKET
9.1.2.4. INDIA DIABETES MARKET
9.1.2.5. MARKET TRENDS
9.1.3. AUSTRALIA
9.1.3.1. MARKET TRENDS
9.1.4. JAPAN
9.1.4.1. JAPAN HEALTH AND HEALTHCARE
9.1.4.2. JAPAN PHARMACEUTICAL MARKET
9.1.4.3. JAPAN DIABETES MARKET
9.1.4.4. MARKET TRENDS
9.1.5. SOUTH KOREA
9.1.5.1. MARKET TRENDS
9.1.6. INDONESIA
9.1.6.1. MARKET TRENDS
9.1.7. MALAYSIA
9.1.7.1. MARKET TRENDS
9.1.8. PHILIPPINES
9.1.8.1. MARKET TRENDS
9.1.9. THAILAND
9.1.9.1. MARKET TRENDS
9.1.10. VIET NAM
9.1.10.1. MARKET TRENDS
9.1.11. REST OF ASIA-PACIFIC (ROAP)
10. COMPETITIVE LANDSCAPE
10.1. MEDTRONIC
10.1.1. OVERVIEW
10.1.2. PRODUCT PORTFOLIO
10.1.3. STRATEGIC INITIATIVES
10.1.4. SCOT ANALYSIS
10.2. DEXCOM
10.2.1. OVERVIEW
10.2.2. PRODUCT PORTFOLIO
10.2.3. STRATEGIC INITIATIVES
10.2.4. SCOT ANALYSIS
10.3. ABBOTT
10.3.1. OVERVIEW
10.3.2. PRODUCT PORTFOLIO
10.3.3. STRATEGIC INITIATIVES
10.3.4. SCOT ANALYSIS
10.4. JOHNSON AND JOHNSON
10.4.1. OVERVIEW
10.4.2. PRODUCT PORTFOLIO
10.4.3. STRATEGIC INITIATIVES
10.4.4. SCOT ANALYSIS
10.5. INSULET CORP
10.5.1. OVERVIEW
10.5.2. PRODUCT PORTFOLIO
10.5.3. STRATEGIC INITIATIVES
10.5.4. SCOT ANALYSIS
10.6. TANDEM DIABETES CARE
10.6.1. OVERVIEW
10.6.2. PRODUCT PORTFOLIO
10.6.3. STRATEGIC INITIATIVES
10.6.4. SCOT ANALYSIS
10.7. ECHO THERAPEUTICS INC
10.7.1. OVERVIEW
10.7.2. PRODUCT PORTFOLIO
10.7.3. STRATEGIC INITIATIVES
10.7.4. SCOT ANALYSIS
10.8. ROCHE DIAGNOSTICS
10.8.1. OVERVIEW
10.8.2. PRODUCT PORTFOLIO
10.8.3. STRATEGIC INITIATIVES
10.8.4. SCOT ANALYSIS
10.9. NEMAURA MEDICAL INC
10.9.1. OVERVIEW
10.9.2. PRODUCT PORTFOLIO
10.9.3. STRATEGIC INITIATIVES
10.9.4. SCOT ANALYSIS
10.10. SENSEONICS INC
10.10.1. OVERVIEW
10.10.2. PRODUCT PORTFOLIO
10.10.3. STRATEGIC INITIATIVES
10.10.4. SCOT ANALYSIS
10.11. GLYSENS INC
10.11.1. OVERVIEW
10.11.2. PRODUCT PORTFOLIO
10.11.3. STRATEGIC INITIATIVES
10.11.4. SCOT ANALYSIS
10.12. TERUMO
10.12.1. OVERVIEW
10.12.2. PRODUCT PORTFOLIO
10.12.3. STRATEGIC INITIATIVES
10.12.4. SCOT ANALYSIS
10.13. WOCKHARDT
10.13.1. OVERVIEW
10.13.2. PRODUCT PORTFOLIO
10.13.3. STRATEGIC INITIATIVES
10.13.4. SCOT ANALYSIS
10.14. I-SENS INC
10.14.1. OVERVIEW
10.14.2. PRODUCT PORTFOLIO
10.14.3. STRATEGIC INITIATIVES
10.14.4. SCOT ANALYSIS
10.15. MORPEN LABORATORIES LTD.
10.15.1. OVERVIEW
10.15.2. PRODUCT PORTFOLIO
10.15.3. STRATEGIC INITIATIVE
10.15.4. SCOT ANALYSIS
10.16. APEX BIOTECHNOLOGY CORP.
10.16.1. OVERVIEW
10.16.2. PRODUCT PORTFOLIO
10.16.3. SCOT ANALYSIS
10.17. ARKRAY INC
10.17.1. OVERVIEW
10.17.2. PRODUCT PORTFOLIO
10.17.3. STRATEGIC ANALYSIS
10.17.4. SCOT ANALYSIS
10.18. B BRAUN MELSUNGEN AG
10.18.1. OVERVIEW
10.18.2. PRODUCT PORTFOLIO
10.18.3. SCOT ANALYSIS
10.18.4. STRATEGIC ANALYSIS
10.19. ASCENSIA
10.19.1. OVERVIEW
10.19.2. PRODUCT PORTFOLIO
10.19.3. SCOT ANALYSIS
10.19.4. STRATEGIC ANALYSIS

TABLE LIST
TABLE 1 ASIA PACIFIC CGMS MARKET, 2018-2026($ MILLION)
TABLE 2 ASIA PACIFIC SMBG MARKET, 2018-2026 ($ MILLION)
TABLE 3 ASIA PACIFIC CGMS MARKET, BY COMPONENT TYPE, 2018-2026($ MILLION)
TABLE 4 ASIA PACIFIC CGMS SENSORS MARKET, 2018-2026 ($ MILLION)
TABLE 5 ASIA PACIFIC CGMS TRANSMITTERS AND RECEIVERS MARKET, 2018-2026 ($ MILLION)
TABLE 6 ASIA PACIFIC CGMS INSULIN PUMP MARKET, 2018-2026 ($ MILLION)
TABLE 7 ASIA PACIFIC CGMS MARKET, BY APPLICATION 2018-2026 ($ MILLION)
TABLE 8 ASIA PACIFIC CGMS HOME SETTINGS MARKET, 2018-2026 ($ MILLION)
TABLE 9 ASIA PACIFIC CGMS DIAGNOSTICS AND CLINICAL MARKET, 2018-2026 ($ MILLION)
TABLE 10 ASIA PACIFIC CGMS HOSPITAL MARKET, 2018-2026 ($ MILLION)
TABLE 11 IMPORTANT ASPECTS FOR USE OF SMBG DEVICES IN HOME-CARE SETTINGS
TABLE 12 PRODUCT MATRIX FOR LANCETS
TABLE 13 ASIA PACIFIC SMBG MARKET, BY COMPONENT TYPE, 2018-2026 ($ MILLION)
TABLE 14 ASIA PACIFIC SMBG LANCETS MARKET, 2018-2026 ($ MILLION)
TABLE 15 ASIA PACIFIC SMBG HOME SETTING MARKET, 2018-2026 ($ MILLION)
TABLE 16 ASIA PACIFIC SMBG CLINICAL MARKET, 2018-2026 ($ MILLION)
TABLE 17 ASIA PACIFIC SMBG HOSPITALS MARKET, 2018-2026 ($ MILLION)
TABLE 18 ASIA PACIFIC SMBG MARKET, 2018-2026 ($ MILLION)
TABLE 19 ASIA PACIFIC CGMS MARKET REVENUE, 2018-2026($ MILLION)
TABLE 20 ASIA-PACIFIC SMBG MARKET REVENUE 2018-2026($ MILLION)
TABLE 21 AVERAGE PRICES IN CHINA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
TABLE 22 CHINA SMBG SALES CHANNEL 2018-2026 ($ MILLION)
TABLE 23 AVERAGE PRICES IN INDIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 24 INDIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)
TABLE 25 AVERAGE PRICES IN AUSTRALI FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 26 AUSTRALIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)
TABLE 27 AVERAGE PRICES IN JAPAN FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 28 JAPAN SALES CHANNEL 2018-2026 ($ MILLION)
TABLE 29 AVERAGE PRICES IN SOUTH KOREA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 30 SOUTH KOREA SMBG SALES CHANNEL 2018-2026 ($ MILLION)
TABLE 31 AVERAGE PRICES IN INDONESIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 32 INDONESIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)
TABLE 33 AVERAGE PRICES IN MALAYSIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 34 MALAYSIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)
TABLE 35 AVERAGE PRICES IN PHILIPPINES FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 36 PHILIPPINES SMBG SALES CHANNEL 2018-2026 ($ MILLION)
TABLE 37 AVERAGE PRICES IN THAILAND FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 38 THAILAND SMBG SALES CHANNEL 2018-2026 ($ MILLION)
TABLE 39 AVERAGE PRICES IN VIETNAM FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 40 VIETNAM SMBG SALES CHANNEL 2018-2026 ($ MILLION)

FIGURES LIST
FIGURE 1 ASIA PACIFIC CGMS SENSORS MARKET, 2018-2026($ MILLION)
FIGURE 2 ASIA PACIFIC CGMS TRANSMITTERS AND RECEIVERS MARKET, 2018-2026($ MILLION)
FIGURE 3 ASIA PACIFIC CGMS INSULIN PUMP MARKET, 2018-2026($ MILLION)
FIGURE 4 ASIA PACIFIC CGMS SHARE, BY APPLICATION 2017 & 2026 (%)
FIGURE 5 ASIA PACIFIC CGMS HOME SETTING MARKET, 2018-2026($ MILLION)
FIGURE 6 ASIA PACIFIC CGMS DIAGNOSTICS AND CLINICAL MARKET, 2018-2026($ MILLION)
FIGURE 7 ASIA PACIFIC CGMS HOSPITAL MARKET, 2018-2026($ MILLION)
FIGURE 8 ASIA PACIFIC SMBG MARKET SHARE, BY COMPONENT TYPE 2017 & 2026(%)
FIGURE 9 ASIA PACIFIC SMBG TEST STRIPS MARKET, 2018-2026 ($ MILLION)
FIGURE 10 ASIA PACIFIC SMBG TEST STRIPS MARKET, 2018-2026 ($ MILLION)
FIGURE 11 ASIA PACIFIC SMBG GLUCOSE METER MARKET, 2018-2026 ($ MILLION)
FIGURE 12 ASIA PACIFIC SMBG GLUCOSE METER MARKET, 2018-2026 ($ MILLION)
FIGURE 13 ASIA PACIFIC SMBG LANCETS MARKET, 2018-2026 ($ MILLION)
FIGURE 14 ASIA PACIFIC SMBG MARKET SHARE, BY APPLICATION 2017& 2026(US $ MILLION)
FIGURE 15 ASIA PACIFIC SMBG HOME SETTING MARKET, 2018-2026 ($ MILLION)
FIGURE 16 ASIA PACIFIC SMBG CLINICAL MARKET, 2018-2026 ($ MILLION)
FIGURE 17 ASIA PACIFIC SMBG HOSPITALS MARKET, 2018-2026 ($ MILLION)
FIGURE 18 ASIA PACIFIC GGMS MARKET SHARE, 2017 & 2026 (%)
FIGURE 19 ASIA-PACIFIC CGMS MARKET REVENUE 2018-2026($ MILLION)
FIGURE 20 CHINA CGMS MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 21 CHINA SMBG MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 22 INDIA CGMS MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 23 INDIA SMBG MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 24 AUSTRALIA CGMS MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 25 AUSTRALIA SMBG MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 26 DEATHS IN AUSTRALIA DUE TO DIABETES
FIGURE 27 JAPAN CGMS MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 28 JAPAN SMBG MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 29 SOUTH KOREA CGMS MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 30 SOUTH KOREA SMBG MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 31 INDONESIA CGMS MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 32 INDONESIA SMBG MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 33 MALAYSIA CGMS MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 34 MALAYSIA SMBG MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 35 PHILIPPINES CGMS MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 36 PHILIPPINES SMBG MARKET REVENUE, 2018-2026 ($ MILLION)
FIGURE 37 THAILAND CGMS MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 38 THAILAND SMBG MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 39 VIETNAM CGMS MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 40 VIETNAM SMBG MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 41 REST OF ASIA-PACIFIC CGMS MARKET REVENUE, 2018-2026($ MILLION)
FIGURE 42 REST OF ASIA-PACIFIC SMBG MARKET REVENUE, 2018-2026($ MILLION)



【レポートのキーワード】

血糖値モニタリング装置

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 血糖値モニタリング装置のアジア市場予測2018-2026(ASIA PACIFIC GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026 )]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆